News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-21 1:31:43 pm Jasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference GlobeNewsWire
2024-03-19 5:0:0 am Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria GlobeNewswire
2024-03-15 5:0:0 am New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia GlobeNewswire
2024-03-04 4:30:0 am Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments GlobeNewswire
2024-02-26 1:30:0 pm Jasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference GlobeNewswire
2024-02-23 5:0:0 am Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting GlobeNewswire
2024-02-07 5:0:0 am Jasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference GlobeNewswire
2024-02-06 5:59:0 am Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock GlobeNewswire
2024-02-05 5:0:0 am Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information